We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Uropathogenic Bacteria Linked to Deadly Disease in Preterm Infants

By LabMedica International staff writers
Posted on 28 Mar 2016
Print article
Image: The application of metagenomic approaches to define the microbiota of the preterm infant gut and implicate uropathogenic Escherichia coli as a risk factor for necrotizing enterocolitis (NEC) and death (Photo courtesy of Chris Sternal-Johnson).
Image: The application of metagenomic approaches to define the microbiota of the preterm infant gut and implicate uropathogenic Escherichia coli as a risk factor for necrotizing enterocolitis (NEC) and death (Photo courtesy of Chris Sternal-Johnson).
Necrotizing enterocolitis (NEC) is an intestinal disease that afflicts about one in ten extremely premature infants and is fatal in nearly one-third of cases.

The premature infant gut is believed to react to colonizing bacteria, causing damage to the intestinal walls and severe infection. An association has been described between necrotizing enterocolitis and a subset of Escherichia coli bacteria, called uropathogenic E. coli (UPEC) that colonize the infant gut.

Scientists at the University of Massachusetts Medical School (Worcester, MA, USA) and their colleagues obtained stool samples from a cohort of 166 infants: 144 preterm and 22 that had been carried to term from hospitals in Cincinnati, Ohio, and Birmingham, Alabama. The team sequenced the infants' stool and developed metagenomic analysis tools to identify the bacteria colonizing each infant. Previous work had already identified Enterobacteriaceae, a family of bacteria that includes E. coli, as potentially associated with NEC.

The team singled out UPEC as the E. coli type most strongly linked to infants who developed NEC. In the study cohort, 27 of the infants developed NEC, all preterm. The disease was fatal in 15 of those cases. UPEC was found in 44% of the infants who developed NEC, compared to only 16% of the 111 infants who survived without developing NEC. Although the team did not address the question of where UPEC in an infant's gut might originate, they did observe an association between vaginal delivery and death from NEC in these extremely preterm infants. Metagenomic multilocus sequence typing analysis further defined NEC-associated strains as sequence types often associated with urinary tract infections, including ST69, ST73, ST95, ST127, ST131, and ST144.

Doyle V. Ward, PhD, a microbiologist and coauthor of the study, said, “Many infants do have UPEC in their gut. It may be that they're colonized when they pass through the birth canal, and this could be a source of risk. We just don't know yet. It's important to realize that infants also acquire many beneficial bacteria from their mothers during vaginal birth and it's likely that the good bacteria have a role in preventing NEC.” The study was published on March 15, 2016, in the journal Cell Reports.

Related Links:

University of Massachusetts Medical School


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.